Danaher acquires Life Technologies' mass spectrometry business

Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation (NYSE: DHR) for $450 million in cash, subject to a conventional working capital adjustment.

Danaher has also acquired Life Technologies’ joint venture partner in the business, MDS Analytical Technologies, a division of MDS Inc. (NYSE: MDZ). Mass spectrometers are highly sensitive and sophisticated instruments used by researchers and clinicians to identify and quantify specific molecules in complex samples.

As previously announced, Life Technologies does not expect the sale of its mass spectrometry business to affect its previously announced 2009 and 2010 earnings expectations.

Source: Life Technologies Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Danaher. (2010, February 02). Danaher acquires Life Technologies' mass spectrometry business. News-Medical. Retrieved on February 03, 2023 from https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx.

  • MLA

    Danaher. "Danaher acquires Life Technologies' mass spectrometry business". News-Medical. 03 February 2023. <https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx>.

  • Chicago

    Danaher. "Danaher acquires Life Technologies' mass spectrometry business". News-Medical. https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx. (accessed February 03, 2023).

  • Harvard

    Danaher. 2010. Danaher acquires Life Technologies' mass spectrometry business. News-Medical, viewed 03 February 2023, https://www.news-medical.net/news/20100202/Danaher-acquires-Life-Technologies-mass-spectrometry-business.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
PerkinElmer to purchase remaining interest of ICP-MS joint venture from Danaher